Literature DB >> 21523638

[Hypertension and hypokalemia - a reninoma as the cause of suspected liquorice-induced arterial hypertension].

C Schulze zur Wiesch1, N Sauer, J Aberle.   

Abstract

HISTORY AND CLINICAL
FINDINGS: A 28-year-old woman presented with dizziness and arterial hypertension. She reported a daily intake of 300 mg liquorice. INVESTIGATIONS: Laboratory analysis revealed hypokalaemia of 2.5 mmol/l and an elevated serum renin activity of 18.6 µg/l/h. Abdominal ultrasound and magnetic resonance imaging showed a circumscribed non-homogenuous round lesion (18 × 22 mm) in the upper third of the right kidney. Selective catheterization of the renal veins revealed increased renin activity in blood from the right renal vein, suggestive of a renin-producing tumor. TREATMENT AND COURSE: Initially antihypertensive therapy with the direct renin receptor antagonist aliskiren was started and followed by a partial nephrectomy, which brought about adequate blood pressure and potassium levels.
CONCLUSION: The constellation of hypokalaemia and hypertension often leads to important causes of secondary hypertension such as primary hyperaldosteronism or renal artery stenosis. But less frequent causes should also be considered in the differential diagnoses, such as liquorice overindulgence or reninoma. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523638     DOI: 10.1055/s-0031-1275821

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

Review 1.  Juxtaglomerular Cell Tumor: Reviewing a Cryptic Cause of Surgically Correctable Hypertension.

Authors:  Rafid Inam; Jason Gandhi; Gunjan Joshi; Noel L Smith; Sardar Ali Khan
Journal:  Curr Urol       Date:  2019-09-10

Review 2.  Bioactive Candy: Effects of Licorice on the Cardiovascular System.

Authors:  Mikkel R Deutch; Daniela Grimm; Markus Wehland; Manfred Infanger; Marcus Krüger
Journal:  Foods       Date:  2019-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.